Erythromelalgia
Showing 1 - 24 of 24
Erythromelalgia Trial in Rochester, Erlangen (Amitriptyline Hydrochloride, Placebo)
Not yet recruiting
- Erythromelalgia
- Amitriptyline Hydrochloride
- Placebo
-
Rochester, Minnesota
- +1 more
Jun 14, 2023
Erythromelalgia Trial in Norway (Burst Spinal Cord Stimulation, Sham spinal cord stimulation)
Recruiting
- Erythromelalgia
- Burst Spinal Cord Stimulation
- Sham spinal cord stimulation
-
Halden, Norway
- +3 more
Sep 20, 2022
Inherited Erythromelalgia Trial in New Haven (PF-05089771, Placebo)
Completed
- Inherited Erythromelalgia
- PF-05089771
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Nov 18, 2019
Painful Channelopathies Study
Unknown status
- Erythromelalgia
- +3 more
- Observation
-
Oxford, Oxfordshire, United KingdomNuffield Department of Clinical Neurosciences
Sep 16, 2019
Healthy Trial in Oslo (ODI-Tech medical device)
Recruiting
- Healthy
- ODI-Tech medical device
-
Oslo, NorwayODI Medical
Nov 2, 2022
Epigenetic Age on Clinic-biological Presentation and Prognosis
Not yet recruiting
- Myeloproliferative Neoplasm
- Assessment of the epigenetic age
-
Bordeaux, FranceCHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023
Erythermalgia Trial in Paris (impedance measurement and pain evaluation)
Completed
- Erythermalgia
- impedance measurement and pain evaluation
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Apr 24, 2019
Monocytes Sub-populations in Thrombosis Associated With
Recruiting
- Myeloproliferative Neoplasm
- 1 additional tube of blood
-
Bordeaux, France
- +4 more
Nov 30, 2022
Biometric and Biological Data for Diagnosis and Therapy of Pain
Recruiting
- Small Fiber Neuropathy
-
Aachen, Nordrhein-Westfalen, GermanyUniklinik RWTH Aachen, Klinik für Palliativmedizin
Apr 6, 2021
Thrombosis Trial in Assiut (myeloproliferative neoplasms)
Recruiting
- Thrombosis
- myeloproliferative neoplasms
-
Assiut, EgyptClinical Hematology Unit
Feb 18, 2021
Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Germany (Ruxolitinib, BAT)
Active, not recruiting
- Polycythemia Vera (PV)
- Essential Thrombocythemia (ET)
-
Mannheim, Baden-Württemberg, Germany
- +23 more
Oct 6, 2020
Causes Associated With Small Fiber Neuropathy (SFN).
Unknown status
- Small Fiber Neuropathy
-
Brest, FranceCHRU de Brest
Nov 18, 2019
Erythromelalgia Trial in New Haven, West Haven (Carbamazepine, Placebo)
Pain In Neuropathy Study
Unknown status
- Diabetic Neuropathy
- +4 more
- Observation
-
Oxford, Oxfordshire, United KingdomNuffield Department of Clinical Neurosciences
Sep 16, 2019
NSCLC Trial in Worldwide (Gefitinib, Placebo, Pemetrexed)
Small Fiber Neuropathy Trial in Maastricht (Lacosamide, Placebo)
Completed
- Small Fiber Neuropathy
- Lacosamide
- Placebo
-
Maastricht, NetherlandsMaastricht University Medical Center
Jan 9, 2018
MPN, Essential Thrombocythemia Trial in Creteil (Aspirin therapy interruption, Usual treatment by aspirin 100 mg/d in the active
Recruiting
- MPN
- Essential Thrombocythemia
- Aspirin therapy interruption
- +3 more
-
Creteil, FranceHenri Mondor Hospital
Jul 24, 2017
Diffuse Large B-cell Lymphoma Trial in Worldwide (Everolimus, Everolimus Placebo)
Completed
- Diffuse Large B-cell Lymphoma
- Everolimus
- Everolimus Placebo
-
Chandler, Arizona
- +201 more
Jun 14, 2017
Primary Erythromelalgia, Inherited Erythromelalgia Trial in Anniston (XPF-002, Placebo)
Completed
- Primary Erythromelalgia
- Inherited Erythromelalgia
- XPF-002
- Placebo
-
Anniston, AlabamaPinnacle Research Group, LLC.
Mar 10, 2014
Primary Erythromelalgia, Inherited Erythromelalgia Trial in Nijmegen (XPF-001, Placebo)
Completed
- Primary Erythromelalgia
- Inherited Erythromelalgia
- XPF-001
- Placebo
-
Nijmegen, NetherlandsClinical Research Centre at Radboud University Nijmegen Medical
Mar 14, 2012